文献速递乳腺癌放疗放疗物理与技术

质子或光子乳房切除术后放疗后即刻两阶段乳房重建结局

Immediate 2-Stage breast reconstruction outcomes after proton or photon postmastectomy radiotherapy.
PubMed 文献 · Clin Transl Radiat Oncol · 2025-07-13

2年手术部位感染(SSI)累积风险为17.83%,非计划再手术为16.19%,重建失败率为7.60%;预防性使用Mepitel Film可降低SSI和非计划再手术风险。

要点

  • 2年SSI累积风险17.83%,非计划再手术16.19%,重建失败率7.60%。
  • 预防性使用Mepitel Film降低SSI风险(HR 0.35)和非计划再手术风险(HR 0.39)。
  • 胸壁推量(HR 4.98)和淋巴结推量(HR 3.66)与重建失败相关(单因素分析)。

核心结论

  • 尽管约五分之一患者发生SSI或非计划再手术,但重建失败率较低(7.6%),多数患者经光子或质子PMRT后获得成功重建。

主要发现

  • 2年SSI累积风险为17.83%(95%CI 12.27-24.41%),非计划再手术为16.19%(95%CI 10.06-22.10%),重建失败为7.60%(95%CI 3.55-12.11%)。
  • 多因素分析显示预防性使用Mepitel Film降低SSI风险(HR 0.35,95%CI 0.18-0.69,p=0.002)和非计划再手术风险(HR 0.39,95%CI 0.20-0.79,p=0.008)。
  • 重建失败事件数少(n=16),无法进行多因素分析;单因素分析显示接受胸壁推量(HR 4.98,95%CI 1.12-22.10,p=0.035)和/或淋巴结推量(HR 3.66,95%CI 1.25-10.73,p=0.018)与重建失败相关。

临床怎么用

  • 对于接受PMRT的即刻乳房重建患者,可考虑预防性使用Mepitel Film以降低SSI和非计划再手术风险,但需进一步评估。
  • 胸壁推量或淋巴结推量可能与重建失败风险升高相关,临床决策时需权衡。

局限性

  • 回顾性研究设计,重建失败事件数少(n=16),无法进行多因素分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the impact of postmastectomy radiotherapy (PMRT) on immediate breast reconstruction (IBR) outcomes among patients treated with proton or photon radiotherapy. MATERIAL AND METHODS: Patients who had undergone mastectomy, immediate breast reconstruction, and PMRT at our institution were included in a retrospective analysis of risk factors for surgical site infection (SSI), unplanned reoperation, and reconstruction failure. Univariate Cox models were used to examine associations of variables with reconstruction outcomes. RESULTS: Two-hundred thirty-one women were included, of whom 224 (97.0 %) underwent two-stage IBR with placement of a tissue expander and 7 (3 %) had direct-to-implant IBR. One-hundred sixty-five patients (71.4 %) received proton and 65 (28.6 %) received photon therapy. Twenty-nine patients (12.6 %) received hypofractionation. Median follow-up was 1.8 years. Two-year cumulative risk of SSI was 17.83 % (95 % CI 12.27-24.41 %); unplanned reoperation was 16.19 % (95 % CI 10.06-22.10 %); and reconstruction failure was 7.60 % (95 % CI 3.55-12.11). On multivariable analysis, prophylactic use of Mepitel Film reduced the risk of SSI [HR: 0.35 (95 % CI: 0.18-0.69), p = 0.002] and unplanned reoperation [HR: 0.39 (95 % CI: 0.20-0.79), p = 0.008]. The small number of events (n = 16) precluded multivariable analysis of reconstruction failure; on univariate analysis, receipt of a chest wall boost [HR: 4.98 (95 % CI: 1.12-22.10), p = 0.035] and/or lymph node boost [HR: 3.66 (95 % CI: 1.25-10.73), p = 0.018] were associated with reconstruction failure. CONCLUSIONS: Although approximately one-fifth of women experienced SSI or unplanned reoperation, the rate of reconstruction failure was low (7.6%) and most women achieved a successful reconstruction outcome with PMRT using photons or protons. The lower rate of SSI and unplanned reoperation with use of Mepitel Film highlights the need for further evaluation.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Gao RW, Harmsen WS, Smith NL, et al. Immediate 2-Stage breast reconstruction outcomes after proton or photon postmastectomy radiotherapy. Clin Transl Radiat Oncol. 2025. PMID: 40698021. doi:10.1016/j.ctro.2025.101015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。